CDC Warns of Anxiety-related Adverse Events

The COVID-19 vaccine providers have been urged by the US Centers for Disease Control and Prevention (CDC) to be aware of the anxiety-related events after vaccination.

The CDC received reports of clusters of anxiety-related events after //administration of the Johnson & Johnson's COVID-19 vaccine on April 7 from five mass vaccination sites, all in different states, 5 weeks after the vaccine got authorization for emergency use in the country.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘Syncope and other anxiety-related events can occur after COVID-19 vaccination, said the CDC.’

Tweet it Now

Overall, 64 anxiety-related events, including 17 reports of syncope, an anxiety-related event, among 8,624 Johnson & Johnson COVID-19 vaccine recipients, were reported from these sites for vaccines administered during April 7 to 9, according to the CDC.

It is important that vaccination providers are aware that anxiety-related adverse events might be reported more frequently after receipt of the Johnson & Johnson COVID-19 vaccine than after influenza vaccination, said the CDC.

The agency urged vaccination providers to observe all COVID-19 vaccine recipients for any adverse reactions for at least 15 minutes after vaccine administration.

Fainting / Syncope - Symptom Evaluation
Fainting or syncope is characterized by transient loss of consciousness and a spontaneous recovery.

Source-IANS

Anxiety Screening Test
Are you anxious to know your anxiety level? Use Medindia’s Anxiety Screening Test, a simple online screening test for anxiety symptoms.

AstraZeneca's COVID Vaccine Benefits More Compared to Risks
Pausing AstraZeneca vaccinations because of suspected links to deadly blood clots could cause COVID-19 to spread, cause more deaths.